Key result
E-5510 significantly decreased normalized platelet deposition at 72 hours in 3 treated patients, while deposition increased progressively in 4 nonmedicated patients.
Why the study?
Does E-5510 reduce platelet deposition on aortic bifurcation grafts in patients undergoing aortofemoral bypass?
RCT (n=7)
randomized
Does E-5510 reduce platelet deposition on aortic bifurcation grafts in patients undergoing aortofemoral bypass?
E-5510 demonstrates potential to inhibit excessive platelet deposition on recently implanted aortic bifurcation grafts.
Answers are grounded in this paper and cite their sources.
E-5510 may curb early platelet deposition on aortic grafts; extends RCT evidence for antiplatelet effects in aortofemoral bypass.
The effects of a recently synthesized anti-platelet aggregation drug (E-5510) on platelet deposition in a knitted Dacron aortic graft underwent preliminary evaluation by In-111 oxime labeled platelet imaging. Seven patients undergoing aortofemoral bypass using this graft for occlusive disease were randomized into two groups: those receiving E-5510 and those receiving no medication. This agent was administered for 17 days postoperatively, and on the 14th day In-111 platelets were injected and images were acquired at 24, 48, and 72 hours. Platelet deposits in the grafts were assessed by the ratios of graft radioactivity to that of the adjacent native iliac arteries. Platelet deposition at the sites of anastomosis and deposition along the entire graft were normalized by initial deposition at 24 hours, and had significantly decreased at 72 hours in the three treated patients, while the normalized deposition increased progressively over time in the remaining four nonmedicated patients. E-5510 seems to have the potential to inhibit excessive platelet deposition on recently implanted grafts.
No takes yet. Share an insight, caveat, or question.
Suga et al. (1998) conducted an RCT in occlusive disease (n=7). E-5510 vs. no medication was evaluated on Platelet deposition in the grafts assessed by the ratios of graft radioactivity to adjacent native iliac arteries. E-5510 significantly decreased normalized platelet deposition at 72 hours in 3 treated patients, while deposition increased progressively in 4 nonmedicated patients.
Synapse has enriched 10 related papers. Consider them for comparative context: